CAS RN: 22785-43-9
S-3-N-Cbz-amino-2,6-Dioxo-piperidine
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250918 |
250mg / 1g / 5g / 10g |
Out of stock |
8-10 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g, 25g, 10g
- Available purity: ≥97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 22785-43-9
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
≥97% |
5
In Stock
|
Shenzhen |
Inquiry |
| 1g |
≥97% |
5
In Stock
|
Beijing |
Inquiry |
| 5g |
≥97% |
5
In Stock
|
Shanghai |
Inquiry |
| 25g |
≥97% |
5
In Stock
|
Shanghai |
Inquiry |
| 10g |
≥97% |
2
In Stock
|
Shanghai |
Inquiry |
22785-43-9 / benzyl N-(2,6-dioxopiperidin-3-yl)carbamate
Standard CAS: 22785-43-9
Multi CAS: No
Basic Information
CAS
22785-43-9
Multi CAS
No
Molecular Formula
C13H14N2O4
Molecular Weight
262.260000
Exact Mass
262.095357
SMILES
C1CC(=O)NC(=O)C1NC(=O)OCC2=CC=CC=C2
InChI
InChI=1S/C13H14N2O4/c16-11-7-6-10(12(17)15-11)14-13(18)19-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,18)(H,15,16,17)/t10-/m0/s1
InChIKey
JJFWWAGUYKLJRN-JTQLQIEISA-N
Computed Properties
Structural Parameters
Heavy atom count
19
Aromatic heavy atom count
6
Fraction Csp3
0.31
Rotatable bonds
3
H-bond acceptors
4
H-bond donors
2
Molar refractivity
65.93
TPSA
84.5
LogP / Solubility
WLOGP
0.72
MLOGP
0.64
XLogP3
0.7
Consensus LogP
0.69
Log S (ESOL)
-1.95
Class (ESOL)
Soluble
Log S (Ali)
-2.23
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.32
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.81
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2